Is checkpoint inhibitor pneumonitis underreported in patients with advanced non-small cell lung cancer (NSCLC) on PD-1 inhibitor monotherapy?

被引：1
|
作者：
Spieler, Benjamin Oren
Lopes, Gilberto
Dal Pra, Alan
Diwanji, Tejan
Yechieli, Raphael
Freedman, Laura M.
Mihaylov, Ivaylo
机构：
[1] Univ Miami, Miller Sch Med, Miami, FL 33136 USA
[2] Univ Miami Hlth Syst, Miami, FL USA
[3] Univ Miami, Sylvester Comprehens Canc Ctr, Miami, FL USA
[4] Univ Miami, Parkland, FL USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2020年 / 38卷 / 15期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
9579
引用
收藏
页数：2
相关论文
共 50 条
  • [21] Quantification of preexisting lung ground glass opacities on CT for predicting checkpoint inhibitor pneumonitis in advanced non-small cell lung cancer patients
    Xinyue Wang
    Jinkun Zhao
    Ting Mei
    Wenting Liu
    Xiuqiong Chen
    Jingya Wang
    Richeng Jiang
    Zhaoxiang Ye
    Dingzhi Huang
    BMC Cancer, 24
  • [22] Quantification of preexisting lung ground glass opacities on CT for predicting checkpoint inhibitor pneumonitis in advanced non-small cell lung cancer patients
    Wang, Xinyue
    Zhao, Jinkun
    Mei, Ting
    Liu, Wenting
    Chen, Xiuqiong
    Wang, Jingya
    Jiang, Richeng
    Ye, Zhaoxiang
    Huang, Dingzhi
    BMC CANCER, 2024, 24 (01)
  • [23] Harmonization radiomics model to predict immune checkpoint inhibitor-related pneumonitis (CIP) in patients with non-small cell lung cancer (NSCLC)
    Yadav, Monica
    Lee, Jeeyeon
    Kim, Haseok
    Lee, Seyoung
    Um, Taegyu
    Lee, Salie
    Djunadi, Trie Arni
    Chung, Liam Il Young
    Yu, Jisang
    Rodrigues, Darren
    Gennaro, Nicolo
    Kim, Leeseul
    Kim, Yuchan
    Nam, Myungwoo
    Hong, Ilene
    Jang, Jessica
    Cho, Amy
    Kang, Grace
    Velichko, Yury
    Chae, Young Kwang
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
  • [24] Association of human leukocyte antigen (HLA) status with immune checkpoint inhibitor (ICI) pneumonitis in patients with non-small cell lung cancer (NSCLC)
    Li, Molly S. C.
    Cheung, Alvin H. K.
    Mui, Zeta
    Chow, Chit
    Lau, Yat Ming
    Wong, Kit Yee
    Kang, Wei
    To, Ka Fai
    Mok, Tony S. K.
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
  • [25] Cancer pathways analysis and correlation with survival in patients with advanced stage non-small cell lung cancer treated with PD-1 inhibitor.
    Tagliamento, Marco
    De Luca, Giuseppa
    Dal Bello, Maria Giovanna
    Longo, Luca
    Dellepiane, Chiara
    Rossi, Giovanni
    Zullo, Lodovica
    Bennicelli, Elisa
    Ferro, Jacopo
    Alama, Angela
    Mora, Marco
    Pronzato, Paolo
    Coco, Simona
    Genova, Carlo
    JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (15)
  • [26] Efficacy and safety of immune checkpoint inhibitor monotherapy in pretreated elderly patients with non-small cell lung cancer
    Ou Yamaguchi
    Hisao Imai
    Hiroyuki Minemura
    Kensuke Suzuki
    Satoshi Wasamoto
    Yukihiro Umeda
    Takashi Osaki
    Norimitsu Kasahara
    Junji Uchino
    Tomohide Sugiyama
    Shinichi Ishihara
    Hisashi Ishii
    Ichiro Naruse
    Keita Mori
    Mie Kotake
    Kenya Kanazawa
    Koichi Minato
    Hiroshi Kagamu
    Kyoichi Kaira
    Cancer Chemotherapy and Pharmacology, 2020, 85 : 761 - 771
  • [27] Efficacy and safety of immune checkpoint inhibitor monotherapy in pretreated elderly patients with non-small cell lung cancer
    Yamaguchi, Ou
    Imai, Hisao
    Minemura, Hiroyuki
    Suzuki, Kensuke
    Wasamoto, Satoshi
    Umeda, Yukihiro
    Osaki, Takashi
    Kasahara, Norimitsu
    Uchino, Junji
    Sugiyama, Tomohide
    Ishihara, Shinichi
    Ishii, Hisashi
    Naruse, Ichiro
    Mori, Keita
    Kotake, Mie
    Kanazawa, Kenya
    Minato, Koichi
    Kagamu, Hiroshi
    Kaira, Kyoichi
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2020, 85 (04) : 761 - 771
  • [28] Early mortality factors in immune checkpoint inhibitor monotherapy for advanced or metastatic non-small cell lung
    Takeuchi, Eiji
    Kondo, Kensuke
    Okano, Yoshio
    Ichihara, Seiya
    Kunishige, Michihiro
    Kadota, Naoki
    Machida, Hisanori
    Hatakeyama, Nobuo
    Naruse, Keishi
    Ogino, Hirokazu
    Nokihara, Hiroshi
    Shinohara, Tsutomu
    Nishioka, Yasuhiko
    ANNALS OF ONCOLOGY, 2023, 34 : S1395 - S1396
  • [29] Impact of losing adipose tissue on outcomes from PD-1/PD-L1 inhibitor monotherapy in non-small cell lung cancer
    Nishioka, Naoya
    Naito, Tateaki
    Miyawaki, Taichi
    Yabe, Michitoshi
    Doshita, Kosei
    Kodama, Hiroaki
    Miyawaki, Eriko
    Iida, Yuko
    Mamesaya, Nobuaki
    Kobayashi, Haruki
    Omori, Shota
    Ko, Ryo
    Wakuda, Kazushige
    Ono, Akira
    Kenmotsu, Hirotsugu
    Murakami, Haruyasu
    Takayama, Koichi
    Takahashi, Toshiaki
    THORACIC CANCER, 2022, 13 (10) : 1496 - 1504
  • [30] Long-term responders to PD-1 blockade in patients with advanced non-small cell lung cancer (NSCLC).
    Luo, Jia
    Bandlamudi, Chaitanya
    Ricciuti, Biagio
    Vokes, Natalie
    Schoenfeld, Adam Jacob
    Egger, Jacklynn, V
    Sauter, Jennifer L.
    Plodkowski, Andrew J.
    Preeshagul, Isabel Ruth
    Kris, Mark G.
    Van Allen, Eliezer Mendel
    Taylor, Barry S.
    Rizvi, Hira
    Donoghue, Mark
    Awad, Mark M.
    Hellmann, Matthew David
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)
12345